Allosteric inhibition rescues hydrocephalus caused by catalytically inactive Shp2 in mice

SHP2, a protein tyrosine phosphatase (PTP) crucial in Ras-MAPK signaling, is associated with various human congenital diseases and cancers. Here, we show that the catalytically inactive Shp2C459S mutation results in communicating hydrocephalus, similar to the catalytically activating Shp2E76K and Mek1DD mutants. Unlike previous mutants, however, Shp2C459S/+ mutation uniquely affects ciliary development rather than neurogenesis, leading to structural abnormalities in cilia and impaired ciliary motility. Differential scanning fluorimetry suggested that SHP2C459S, SHP2E76K, and SHP2C459S/E76K mutations all induce an open SHP2 conformation, but only SHP2C459S leads to aberrant GAB1 phosphorylation in cells expressing wild-type SHP2. Consistent with this distinct signaling profile, brain ventricular tissues from Shp2C459S/+ mice exhibit elevated GAB1 and AKT phosphorylation despite normal ERK and STAT3 activities, implicating dysregulated PI3K-AKT signaling in the pathogenesis of hydrocephalus. Importantly, pharmacological inhibition of PI3K markedly rescues ciliogenesis defects and alleviates hydrocephalus in mutant mice. Furthermore, the allosteric SHP2 inhibitor SHP099 increases the thermal stability of SHP2C459S protein, consistent with a shift toward a closed state, and ameliorates hydrocephalus in Shp2C459S/+ mice. These findings suggest that, in this engineered mouse model, Shp2-associated hydrocephalus is driven by conformational changes rather than altered catalytic activity. Our results underscore the therapeutic potential of conformation-specific allosteric inhibitors in targeting both catalytically active and inactive SHP2 mutants.

Authors

Institutions

Publication Details

Journal
PLoS Biology
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pbio.3004113
Citations
4
Primary Topic
Protein Tyrosine Phosphatases
Type
article
Field-Weighted Citation Impact
4.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Allosteric inhibition rescues hydrocephalus caused by catalytically inactive Shp2 in mice

Hilal Ahmad Mir, Ziyuan Jiang, Neoklis Makrides, Emily Sun et al.
4 citations
PLoS Biology
Protein Tyrosine Phosphatases
4.56
article

Allosteric inhibition rescues hydrocephalus caused by catalytically inactive Shp2 in mice

Hilal Ahmad Mir, Ziyuan Jiang, Neoklis Makrides, Emily Sun, Neel H. Shah, John Peregrin, Wellington Veras Cardoso, C Sung, Xin Zhang, Yihua Wu, Jen-Zen Chuang, Qian Wang, Carlos Serra
article en
4 citations

Abstract

SHP2, a protein tyrosine phosphatase (PTP) crucial in Ras-MAPK signaling, is associated with various human congenital diseases and cancers. Here, we show that the catalytically inactive Shp2C459S mutation results in communicating hydrocephalus, similar to the catalytically activating Shp2E76K and Mek1DD mutants. Unlike previous mutants, however, Shp2C459S/+ mutation uniquely affects ciliary development rather than neurogenesis, leading to structural abnormalities in cilia and impaired ciliary motility. Differential scanning fluorimetry suggested that SHP2C459S, SHP2E76K, and SHP2C459S/E76K mutations all induce an open SHP2 conformation, but only SHP2C459S leads to aberrant GAB1 phosphorylation in cells expressing wild-type SHP2. Consistent with this distinct signaling profile, brain ventricular tissues from Shp2C459S/+ mice exhibit elevated GAB1 and AKT phosphorylation despite normal ERK and STAT3 activities, implicating dysregulated PI3K-AKT signaling in the pathogenesis of hydrocephalus. Importantly, pharmacological inhibition of PI3K markedly rescues ciliogenesis defects and alleviates hydrocephalus in mutant mice. Furthermore, the allosteric SHP2 inhibitor SHP099 increases the thermal stability of SHP2C459S protein, consistent with a shift toward a closed state, and ameliorates hydrocephalus in Shp2C459S/+ mice. These findings suggest that, in this engineered mouse model, Shp2-associated hydrocephalus is driven by conformational changes rather than altered catalytic activity. Our results underscore the therapeutic potential of conformation-specific allosteric inhibitors in targeting both catalytically active and inactive SHP2 mutants.

PLoS BiologyVol. 24(11)
Washington University in St. Louis (US), Columbia University Irving Medical Center (US), Weill Cornell Medicine (US), Columbia University (US), University of Minho (PT)
Knights Templar Eye Foundation, Research to Prevent Blindness, Ögonfonden, National Institutes of Health, National Eye Institute, National Institute of General Medical Sciences
Good health and well-being
Openalex Percentile: Top 6%
Protein Tyrosine Phosphatases
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon